elosulfase alfa

Ligand id: 7392

Name: elosulfase alfa

Compound class Peptide or derivative
Approved drug? Yes (EMA & FDA (2014))
International Nonproprietary Names
INN number INN
9686 elosulfase alfa
BMN 110 | rhGALNS | Vimizim®
Elosulfase alfa is a recombinant enzyme replacement therapy for galactosamine (N-acetyl)-6-sulfatase (GALNS, P34059) deficiency. The peptide is translated from the human cDNA expressed in CHO cells [1].
Database Links
CAS Registry No. 9025-60-9 (source: SciFinder)
GtoPdb PubChem SID 178103964
Search PubMed clinical trials elosulfase alfa
Search PubMed titles elosulfase alfa
Search PubMed titles/abstracts elosulfase alfa
Wikipedia Elosulfase_alfa